Your browser doesn't support javascript.
loading
Alemtuzumab mediates the CD39+ T-regulatory cell response via CD23+ macrophages.
Remez, Lital; Ganelin-Cohen, Esther; Safina, Dina; Hellmann, Mark A; Lotan, Itay; Bosak, Noam; Buxbaum, Chen; Vaknin, Adi; Shifrin, Alla; Rozenberg, Ayal.
Afiliação
  • Remez L; Neuroimmunology Laboratory, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Ganelin-Cohen E; Neuroimmunological Clinic, Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Safina D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hellmann MA; Neuroimmunology Laboratory, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Lotan I; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bosak N; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Buxbaum C; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Vaknin A; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Shifrin A; Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Rozenberg A; Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
Immunol Cell Biol ; 99(5): 521-531, 2021 05.
Article em En | MEDLINE | ID: mdl-33306219

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucócitos Mononucleares / Linfócitos T Reguladores Limite: Humans Idioma: En Revista: Immunol Cell Biol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucócitos Mononucleares / Linfócitos T Reguladores Limite: Humans Idioma: En Revista: Immunol Cell Biol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
...